AngioDynamics, Inc. Net Cash Provided by (Used in) Operating Activities, Continuing Operations
AngioDynamics, Inc. (ANGO) reported Net Cash Provided by (Used in) Operating Activities, Continuing Operations of $12.43 million for the 9-month period ending 2019-02-28, per its 10-Q filed 2019-04-02.
Discontinued › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations · last filed 2019-04-02
- AngioDynamics, Inc. net cash provided by (used in) operating activities, continuing operations for the quarter ending 2019-02-28 was $8.34M, a 93.33% increase year-over-year.
- AngioDynamics, Inc. net cash provided by (used in) operating activities, continuing operations for the quarter ending 2018-11-30 was $12.96M, a 27.49% increase year-over-year.
- AngioDynamics, Inc. net cash provided by (used in) operating activities, continuing operations for the quarter ending 2018-08-31 was -$8.87M, a 392.26% decline year-over-year.
- AngioDynamics, Inc. net cash provided by (used in) operating activities, continuing operations for the quarter ending 2018-02-28 was $4.32M, a 69.96% decline year-over-year.
| Period end | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 6 month | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 9 month |
|---|---|---|---|
| 2019-02-28 | $8.34M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-04-02 | $21.30M derived: sum of 2 quarters · filed 2019-04-02 | $12.43M 10-Q · filed 2019-04-02 |
| 2018-11-30 | $12.96M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-01-07 | $4.09M 10-Q · filed 2019-01-07 | |
| 2018-08-31 | -$8.87M 10-Q · filed 2018-10-01 | ||
| 2018-02-28 | $4.32M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-04-02 | $14.48M derived: sum of 2 quarters · filed 2019-04-02 | $17.52M 10-Q · filed 2019-04-02 |
| 2017-11-30 | $10.16M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-01-07 | $13.20M 10-Q · filed 2019-01-07 | |
| 2017-08-31 | $3.04M 10-Q · filed 2018-10-01 | ||
| 2017-02-28 | $14.37M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-04-05 | $29.31M derived: sum of 2 quarters · filed 2018-04-05 | $36.75M 10-Q · filed 2018-04-05 |
| 2016-11-30 | $14.95M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-01-05 | $22.39M 10-Q · filed 2018-01-05 | |
| 2016-08-31 | $7.44M 10-Q · filed 2017-09-29 | ||
| 2016-02-29 | $12.39M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-04-03 | $21.97M derived: sum of 2 quarters · filed 2017-04-03 | $26.67M 10-Q · filed 2017-04-03 |
| 2015-11-30 | $9.58M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-01-06 | $14.28M 10-Q · filed 2017-01-06 | |
| 2015-08-31 | $4.70M 10-Q · filed 2016-10-05 | ||
| 2015-02-28 | $12.23M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-04-11 | $10.08M derived: sum of 2 quarters · filed 2016-04-11 | $15.44M 10-Q · filed 2016-04-11 |
| 2014-11-30 | -$2.15M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-01-08 | $3.21M 10-Q · filed 2016-01-08 | |
| 2014-08-31 | $5.35M 10-Q · filed 2015-10-08 | ||
| 2014-02-28 | -$584.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-04-09 | $7.87M derived: sum of 2 quarters · filed 2015-04-09 | $15.17M 10-Q · filed 2015-04-09 |
| 2013-11-30 | $8.46M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-01-09 | $15.76M 10-Q · filed 2015-01-09 | |
| 2013-08-31 | $7.30M 10-Q · filed 2014-10-15 | ||
| 2013-02-28 | $15.52M 10-Q · filed 2014-04-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |